This proportion is near to that reported by Maxwell et al. in their study on Caucasian and African American BC patients who were BRCA1/2 negative, which identified 11% of patients as carrying non-BRCA1/2 deleterious mutations [60]. The gene discussed is BRCA1; the disease is breast cancer.